Alignment Healthcare Statistics
Total Valuation
ALHC has a market cap or net worth of $4.79 billion. The enterprise value is $4.42 billion.
Important Dates
The next estimated earnings date is Wednesday, July 29, 2026, after market close.
| Earnings Date | Jul 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ALHC has 206.73 million shares outstanding. The number of shares has increased by 5.70% in one year.
| Current Share Class | 206.73M |
| Shares Outstanding | 206.73M |
| Shares Change (YoY) | +5.70% |
| Shares Change (QoQ) | +6.05% |
| Owned by Insiders (%) | 3.38% |
| Owned by Institutions (%) | 100.26% |
| Float | 186.51M |
Valuation Ratios
The trailing PE ratio is 239.89 and the forward PE ratio is 43.19.
| PE Ratio | 239.89 |
| Forward PE | 43.19 |
| PS Ratio | 1.13 |
| Forward PS | 0.87 |
| PB Ratio | 23.17 |
| P/TBV Ratio | 28.16 |
| P/FCF Ratio | 21.20 |
| P/OCF Ratio | 19.02 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 65.75, with an EV/FCF ratio of 19.54.
| EV / Earnings | 223.09 |
| EV / Sales | 1.04 |
| EV / EBITDA | 65.75 |
| EV / EBIT | 121.10 |
| EV / FCF | 19.54 |
Financial Position
The company has a current ratio of 1.58, with a Debt / Equity ratio of 1.59.
| Current Ratio | 1.58 |
| Quick Ratio | 1.39 |
| Debt / Equity | 1.59 |
| Debt / EBITDA | 4.71 |
| Debt / FCF | 1.46 |
| Interest Coverage | 2.29 |
Financial Efficiency
Return on equity (ROE) is 12.53% and return on invested capital (ROIC) is 6.96%.
| Return on Equity (ROE) | 12.53% |
| Return on Assets (ROA) | 2.11% |
| Return on Invested Capital (ROIC) | 6.96% |
| Return on Capital Employed (ROCE) | 6.80% |
| Weighted Average Cost of Capital (WACC) | 10.20% |
| Revenue Per Employee | $2.30M |
| Profits Per Employee | $10,712 |
| Employee Count | 1,849 |
| Asset Turnover | 3.95 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ALHC has paid $24,000 in taxes.
| Income Tax | 24,000 |
| Effective Tax Rate | 0.12% |
Stock Price Statistics
The stock price has increased by +69.27% in the last 52 weeks. The beta is 1.15, so ALHC's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | +69.27% |
| 50-Day Moving Average | 18.79 |
| 200-Day Moving Average | 18.85 |
| Relative Strength Index (RSI) | 72.29 |
| Average Volume (20 Days) | 6,836,393 |
Short Selling Information
The latest short interest is 25.42 million, so 12.30% of the outstanding shares have been sold short.
| Short Interest | 25.42M |
| Short Previous Month | 25.44M |
| Short % of Shares Out | 12.30% |
| Short % of Float | 13.63% |
| Short Ratio (days to cover) | 3.91 |
Income Statement
In the last 12 months, ALHC had revenue of $4.26 billion and earned $19.81 million in profits. Earnings per share was $0.10.
| Revenue | 4.26B |
| Gross Profit | 527.01M |
| Operating Income | 36.49M |
| Pretax Income | 19.82M |
| Net Income | 19.81M |
| EBITDA | 67.20M |
| EBIT | 36.49M |
| Earnings Per Share (EPS) | $0.10 |
Full Income StatementBalance Sheet
The company has $726.29 million in cash and $329.97 million in debt, giving a net cash position of $375.62 million or $1.82 per share.
| Cash & Cash Equivalents | 726.29M |
| Total Debt | 329.97M |
| Net Cash | 375.62M |
| Net Cash Per Share | $1.82 |
| Equity (Book Value) | 206.89M |
| Book Value Per Share | 1.00 |
| Working Capital | 420.61M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $251.99 million and capital expenditures -$25.89 million, giving a free cash flow of $226.10 million.
| Operating Cash Flow | 251.99M |
| Capital Expenditures | -25.89M |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | 226.10M |
| FCF Per Share | $1.09 |
Full Cash Flow StatementMargins
Gross margin is 12.38%, with operating and profit margins of 0.86% and 0.47%.
| Gross Margin | 12.38% |
| Operating Margin | 0.86% |
| Pretax Margin | 0.47% |
| Profit Margin | 0.47% |
| EBITDA Margin | 1.58% |
| EBIT Margin | 0.86% |
| FCF Margin | 5.31% |